Table 2.

Operative variables and early postoperative complications

	Total (n = 109)	Group G (graft inversion) (n = 57)	Group C (conventional) (n = 52)	P value
HCA time	39.19 ± 9.45	36.46 ± 7.88	42.19 ± 10.17	0.001
CA time	168.25 ± 61.33	156.21 ± 55.99	181.44 ± 64.68	0.031
CPB time	234.95 ± 71.88	231.35 ± 72.85	238.90 ± 71.30	0.586
Operation time	366.18 ± 68.70	355.70 ± 70.053	377.67 ± 65.94	0.096
Concomitant procedure
CABG	6 (5.5%)	2 (3.5%)	4 (7.7%)	0.339
AVR	3 (2.8%)	1 (1.8%)	2 (3.8%)	0.505
Bentall	28 (25.7%)	13 (22.8%)	15 (28.8%)	0.471
TVP	3 (2.8%)	2 (3.5%)	1 (1.9%)	0.613
SAS	1 (0.9%)	0	1 (1.9%)	0.293
Re-exploration for bleeding	3 (2.8%)	0	3 (5.8%)	0.066
Hospital mortality	10 (9.2%)	4 (7.0%)	6 (11.5%)	0.414
Major complications
Stroke	7 (6.4%)	3 (5.3%)	4 (7.7%)	0.605
Paraplegia	5 (4.6%)	2 (3.5%)	3 (5.8%)	0.573
Heart failure	6 (5.5%)	3 (5.3%)	3 (5.8%)	0.908
Respiratory failure	19 (17.4%)	11 (19.3%)	8 (15.4%)	0.591
Renal insufficiency (CRRT)	13 (11.9%)	5 (14.0%)	8 (9.6%)	0.287

HCA hypothermic circulatory arrest, CA cardiac arrest, CPB cardiopulmonary bypass, CABG coronary artery bypass grafting, AVR aortic valve replacement, TVP tricuspid valve plasty, SAS subvalvular aortic stenosis, CRRT continuous renal replacement therapy